Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Covista Inc. SEC filings document the company’s transition from Adtalem Global Education Inc. and its ongoing disclosures as a healthcare education company. Recent 8-K filings cover certificate and bylaw amendments for the name change, the related ticker change from ATGE to CVSA, academic and financial results, enrollment trends, guidance updates, and Regulation FD investor materials.
The filings also describe capital-structure and governance matters, including credit agreement amendments, term loan refinancing, senior secured notes redemption, share repurchase authorizations, and annual meeting vote results. These records frame the company’s public-company reporting around healthcare education operations, institutional performance, capital allocation, debt arrangements, and shareholder governance.
Adtalem Global Education, Inc. (ATGE) filed a Form 144 reporting a proposed sale of 12,900 common shares through Goldman Sachs & Co. LLC with an aggregate market value of $1,714,281. The shares represent part of the company's outstanding common stock of 35,955,712 shares and the approximate sale date is 08/21/2025. The filer reports the shares were acquired on 08/28/2023 as compensation in the form of restricted stock units and that payment was by compensation. The filing includes the required representation that the seller is not aware of any undisclosed material adverse information.
Ariel Investments, LLC reported beneficial ownership of 1,375,687 shares of Adtalem Global Education Inc common stock, representing 3.8% of the class. The filing discloses sole voting power over 1,215,284 shares and sole dispositive power over 1,375,687 shares.
The statement certifies the securities are held in the ordinary course of business and were not acquired to change or influence control. Adviser clients have the right to receive dividends or proceeds, and no client is listed with an economic interest exceeding 5% in the reported securities.